which also brought in the encapsulation technology used in VX-264. Since then, the company has expanded its type 1 diabetes cell therapy platform with the $320 million takeover of rival developer ...

Along with VX-880, it is also working on encapsulated islet cells as a treatment for T1D, although that programme remains in preclinical development. Encapsulation could mean doing away with the ...

I got my first tattoo in Puerto Vallarta, Mexico. It was a tribal rose—a classic ’90s design—and an act of rebellion for ...

The global lipid nanoparticles market is on the cusp of remarkable expansion, projected to grow at a CAGR of 14% through 2035, according to a recent industry analysis. Estimated to generate USD 1,144.

A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent ...

A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing ...

The Cocoon® (from Lonza) is a functionally closed, sterile, efficient manufacturing platform, which combined with our ...

Discover how stem cells may help reduce acne scars by boosting collagen, improving skin texture, and speeding up healing—plus ...

This research roundup discusses researchers’ attempts to find a treatment for a “brain fog” that comes with CAR T-Cell ...

Rui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and ...

The IDMO Smart Factory initiative has the potential to help advance the development and approval of CAR-T therapeutics in ...

A team of scientists from the San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget) in Milan, Italy, has identified a ...